Legacy Financial Group (Iowa)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-678
Closed -$39.3K 82
2023
Q3
$39.3K Buy
+678
New +$41.5K 0.01% 200

Other funds holding BMY

Legacy Financial Group (Iowa)'s BMY Position: Q4 2023 in Review

Legacy Financial Group (Iowa) sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 678 shares — an estimated $39.3K sold.

Legacy Financial Group (Iowa) first reported a position in BMY in Q3 2023 and held it in 1 quarter. The position peaked at $39.3K in Q3 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Legacy Financial Group (Iowa) reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Legacy Financial Group (Iowa) sold 678 Bristol-Myers Squibb shares in Q4 2023, an estimated $39.3K.
  • Legacy Financial Group (Iowa) first reported a position in Bristol-Myers Squibb in Q3 2023 and held it in 1 quarter.
  • Legacy Financial Group (Iowa)'s Bristol-Myers Squibb position peaked at $39.3K in Q3 2023.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Legacy Financial Group (Iowa)'s 13F filing for Q4 2023, filed 22 Jan 2024.